Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) has expanded its investor reach to the U.S. by listing its shares on the OTCQB market. The company’s shares will still be traded on the CSE and Frankfurt Exchange.

The OTCQB is a reputable platform for entrepreneurial companies, recognized by the SEC. This move aims to enhance Gemina’s visibility, liquidity, and shareholder base within the U.S.

CEO Brian Firth expressed satisfaction with this development, highlighting the ease it provides U.S. investors in trading Gemina's shares and its strategic alignment with their diagnostics technology business expansion in the U.S.

Current financial disclosures and real-time quotes can be accessed on www.otcmarkets.com. The company's wider North American presence offers premier trading access to investors.